• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Infectious Disease Diagnostic Testing: World Market Analysis

$6,000.00 – $12,000.00

Clear
SKU: 22-022 Categories: Diagnostics Market Research, Immunoassays, Infectious Disease, Molecular & Nucleic Acid Testing, Point-of-Care Diagnostics Tags: COVID-19, Healthcare-associated infections (HAIs) testing market, Hepatitis testing market, HIV/AIDS testing market, Infectious disease testing market, Influenza testing market, STD testing market, TORCH testing market, Tuberculosis testing market Pages: 264
  • Description
  • Table of Contents
  • Latest reports

Description

The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD

 

Attend a WEBINAR on this topic.

 

Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine an appropriate antimicrobial therapy.

Forecasts from 2018 to 2031 for over 70 disease, technology and venue (lab-based POC) categories.   Plus 21 regional& country markets.

Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques. Specific types of tests are available for detecting hundreds of pathogenic conditions. The report examines the global demand for infectious disease IVD products, which is projected to increase as medical providers and healthcare organizations throughout the world heighten efforts to combat proliferating epidemic threats.

Kalorama’s Largest Study Focusing on Clinical Microbiology and Pathogen Detection Diagnostic Tests

This report, Infectious Disease Diagnostic Testing: World Market Analysis, examines the global market for infectious disease testing products. Specific applications analyzed and forecasted out to 2031 include:

  • Healthcare-associated and opportunistic infections (C.diff, Sepsis, MRSA, VRE, Other HAI)
  • HIV (molecular, immunoassay, POC)
  • Hepatitis (molecular, immunoassay, POC, Type C, Type B, Other Types)
  • Antimicrobial-resistant pathogens including bacteria, fungi, parasites, and viruses
  • Human immunodeficiency virus (HIV) and hepatitis viruses
  • Diseases related to women’s health (TORCH)
  • Sexually transmitted infections (Chlamydia, HPV, Gonorrhea, HSV-2, Syphilis), 
  • Emerging, neglected, and tropical disease threats
  • Lyme Disease
  • Malaria
  • Streptococcal Infections
  • Fungal Disease, Parasitic Disease
  • Dengue fever
  • Influenza and RSV  
  • ID/AST (manual and automated)
  • COVID-19 (immunoassay and molecular, analyst’s forecast to 2026)

Superior Geographic and Country Markets Coverage

Opportunities for infectious disease testing products vary widely between the developed and developing countries. Regions and countries covered with additional market breakouts include:

  • Region: North America
  • Region: Eastern Europe
  • Region: Western Europe
  • Region: Asia/Pacific
  • Region: Africa/Middle East
  • Region: Central and South America
  • Region: Other Regions
  • Country – US
  • Country – UK
  • Country – France
  • Country – China
  • Country – Germany
  • Country – Italy
  • Country – Mexico
  • Country – Canada
  • Country – Japan
  • Country – South Korea

For each of these regions, the report contains market size and forecast for the following disease test markets within that region:

  • STIs
  • HAIs
  • ID/AST
  • Hepatitis
  • HIV/AIDS
  • Influenza
  • Tuberculosis
  • TORCH
  • Other Infections 
  • Total (w/o COVID)
  • COVID-19

Market Drivers, Health Statistics and Economics

The report examines market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics. Public health officials worldwide have begun to recognize the global nature of infectious diseases – they are no longer solely a problem of developing countries but touch the very fabric of the social and economic welfare of countries in the industrialized world as well. Over the long term, aging populations and problems posed by infectious diseases will strain healthcare resources in many countries.

Competitive Landscape

The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company’s infectious disease IVD products:

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • DiaSorin S.p.A.
  • Grifols
  • Hologic, Inc.
  • Ortho-Clinical Diagnostics
  • QIAGEN N.V.
  • Quidel Corporation
  • Roche
  • Siemens AG
  • Thermo Fisher Scientific Inc.

The information presented herein is derived from publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author’s industry knowledge combined with literature searches and selected direct interviews with industry experts conducted previously.

Estimates in the report are based on an examination of epidemiological statistics, test pricing, annual reports of key competitors and regional sales, as well as Kalorama Information’s databases and economic composites. Forecasts presented for Eastern Europe were prepared prior to Russia’s invasion of Ukraine and its negative impact on the healthcare systems of both countries.

Table of Contents

Chapter 1: Executive Summary

A Mix of Traditional and Emerging Testing Technologies

Market Drivers

The World Infectious Disease Testing Market

  • Table 1-1a: World Infectious Disease Diagnostic Test Market, 2018-2026 ($ millions)
  • Table 1-1b: World Infectious Disease Diagnostic Test Market, 2027-2031 ($ millions)

Major Findings of the Report

  • Table 1-2: Selected Infectious Diseases, Global Incidence, Prevalence, & Mortality, 2021

Scope and Methodology

 

Chapter 2: Market Environment

Overview

Population

  • Table 2-1a: Population by Country, 2018-2025 (million)
  • Table 2-1b: Population by Country, 2026-2031 (million)

Age Distribution

  • Table 2-2a: Population 50 Years & Older by Country, 2018-2025 (million)
  • Table 2-2b: Population 50 Years & Older by Country, 2026-2031 (million)
  • Table 2-3a: Population 65 Years & Older by Country, 2018-2025 (million)
  • Table 2-3b: Population 65 Years & Older by Country, 2026-2031 (million)

Macroeconomic Environment

Global Economic Outlook

  • Table 2-4a: Gross Domestic Product by Country, 2018-2025 (billion dollars)
  • Table 2-4b: Gross Domestic Product by Country, 2026-2031 (billion dollars)

Per Capita Gross Domestic Product

  • Table 2-5a: Per Capita Gross Domestic Product by Country, 2018-2025 (dollars)
  • Table 2-5b: Per Capita Gross Domestic Product by Country, 2026-2031 (dollars)

Global Healthcare Trends

Infectious Disease Cases

  • Table 2-6a: Number of Infectious Disease Cases by Country, 2018-2025 (million)
  • Table 2-6b: Number of Infectious Disease Cases by Country, 2026-2031 (million)
  • Table 2-7a: Health Expenditures by Country, 2018-2025 (billion dollars)
  • Table 2-7b: Health Expenditures by Country, 2026-2031 (billion dollars)

Medical Providers

  • Table 2-8 Medical Providers, Selected Countries, 2021

Patient Activity

Hospital Admissions

  • Table 2-9a: Hospital Admissions by Country, 2018-2025 (million)
  • Table 2-9b.: Hospital Admissions by Country, 2026-2031 (million)

Inpatient Days

  • Table 2-10a: Inpatient Days by Country, 2018-2025 (million)
  • Table 2-10b: Inpatient Days by Country, 2026-2031 (million)

Surgical Procedures

  • Table 2-11a: Surgical Procedures by Country, 2018-2025 (million)
  • Table 2-11b: Surgical Procedures by Country, 2026-2031 (million)

Outpatient Consultations

  • Table 2-12a: Outpatient Consultations by Country, 2018-2025 (million)
  • Table 2-12b: Outpatient Consultations by Country, 2026-2031 (million)

IVD Tests

  • Table 2-13a: IVD Tests by Country, 2018-2025 (million)
  • Table 2-13b: IVD Tests by Country, 2026-2031 (million)

 

Chapter 3: Infectious Disease IVD Products & Markets

Overview

  • Table 3-1a: Global Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 3-1b: Global Infectious Disease IVD Products Demand by Type, 2026-2031 (million dollars)

Sexually Transmitted Infections (STIs)

  • Table 3-2a: Global Sexually Transmitted Infection IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-2b: Global Sexually Transmitted Infections IVD Products Demand, 2026-2031 (million dollars)

Chlamydia Trachomatis (chlamydia)

Human Papillomavirus (HPV)

Gonorrhea

Herpes Simplex Virus 2 (HSV-2)

Syphilis

Other Sexually Transmitted Disease (STD) IVD Products

Healthcare-Associated Infections

  • Table 3-3a: Global Healthcare-Associated Infection IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-3b: Global Healthcare-Associated Infections IVD Products Demand, 2026-2031 (million dollars)

Clostridium difficile (C. diff)

Sepsis

Methicillin-Resistant Staphylococcus Aureus (MRSA)

Vancomycin-Resistant Enterococcus (VRE)

Other HAIs

Identification & Antibiotic Susceptibility Testing (ID/AST) Products

  • Table 3-4a: Global ID/AST IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-4b: Global ID/AST IVD Products Demand, 2026-2031 (million dollars)

Automated ID/AST Products

Manual Panels & Reagents

Producers

Hepatitis IVD Products

  • Table 3-5a: Global Hepatitis IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-5b: Global Hepatitis IVD Products Demand, 2026-2031 (million dollars)

HIV/AIDS IVD Products

  • Table 3-6a: Global HIV/AIDS IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-6b: Global HIV/AIDS IVD Products Demand, 2026-2031 (million dollars)

Influenza

  • Table 3-7a: Global Influenza IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-7b: Global Influenza IVD Products Demand, 2026-2031 (million dollars)

Tuberculosis (TB)

  • Table 3-8a: Global Tuberculosis IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-8b: Global Tuberculosis IVD Products Demand, 2026-2031 (million dollars)

TORCH

  • Table 3-9a: Global TORCH IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-9b: Global TORCH IVD Products Demand, 2026-2031 (million dollars)

All Other Infectious Disease IVD Products

  • Table 3-10a: Global Other Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-10b: Global Other Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Malaria

Streptococcal Infections

Fungal Infections

Parasitic Conditions

Lyme Disease

Respiratory Syncytial Virus (RSV)

Emerging Infections

Chikungunya

Dengue Fever

Additional Products

COVID-19

  • Table 3-11 Global COVID-19 IVD Products Demand, 2018-2026 (million dollars)

Global Infectious Disease IVD Technologies

  • Table 3-12a: Global Infectious Disease IVD Products Demand by Technology, 2018-2025 (million dollars)
  • Table 3-12b: Global Infectious Disease IVD Products Demand by Technology, 2026-2031 (million dollars)

Immunoassays

  • Table 3-13a: Global Immunoassay Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-13b: Global Immunoassay Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Molecular Technologies

  • Table 3-14a: Global Molecular Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-14b: Global Molecular Infectious Disease IVD Products Demand 2026-2031 (million dollars)

Conventional Microbiology

  • Table 3-15a: Global Microbiology Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-15b: Global Microbiology Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Global Infectious Disease IVD Demand by Market

  • Table 3-16a: Global Infectious Disease IVD Products Demand by Site, 2018-2025 (million dollars)
  • Table 3-16b: Global Infectious Disease IVD Products Demand by Site, 2026-2031 (million dollars)
  • Table 3-17a: Global Laboratory Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-17b: Global Laboratory Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
  • Table 3-18a: Global Point-of-Care Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-18b: Global Point-of-Care Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

TEST TABLES

All Sexually Transmitted Infections

All Healthcare-Associated Infections

All ID/AST

All Hepatitis

All HIV/AIDS

All Influenza

All Tuberculosis

All TORCH

All Other Infections

All Total World (w/o COVID-19)

All COVID-19

SDI Test

Technology:

Immunoassay, 2018-2031

Molecular,  2018-2031

Microbiology, 2018-2031

Site:

Laboratory Tests, 2018-2031

POC Tests , 2018-2031

Pathogen:

Chlamydia, 2018-2031

HPV, 2018-2031

Gonorrhea, 2018-2031

HSV-2 (Herpes Simplex), 2018-2031

Syphilis, 2018-2031

Other STIs, 2018-2031

HAI TESTS

Technology, 2018-2031

Microbiology, 2018-2031

Immunoassay, 2018-2031

Molecular, 2018-2031

Site:

Laboratory Tests, 2018-2031

POC Tests  , 2018-2031

Pathogen/Disorder:

  1. diff, 2018-2031

Sepsis, 2018-2031

MRSA, 2018-2031

VRE, 2018-2031

Other HAIs, 2018-2031

Total World, 2018-2031

ID/AST

Automated Tests, , 2018-2031

Manual Tests,  2018-2031

Total World, , 2018-2031

HEPATITIS

Technology:

Immunoassay, 2018-2031

Molecular, 2018-2031

Site:

Laboratory Tests, 2018-2031

Blood Screens, 2018-2031

POC Tests, 2018-2031

Pathogen/Disorder:

Hepatitis B , 2018-2031

Hepatitis C, 2018-2031

Other, 2018-2031

Total World, 2018-2031

HIV/AIDS

Technology:

Immunoassay, 2018-2031

Molecular, 2018-2031

Site:

Laboratory Tests, 2018-2031

Blood Screens, 2018-2031

POC Tests, 2018-2031

Total World, 2018-2031

INFLUENZA

Technology:

Immunoassay, 2018-2031

Molecular, 2018-2031

Microbiology, 2018-2031

Site:

Laboratory Tests, 2018-2031

POC Tests, 2018-2031

Total World, 2018-2031

TUBERCULOSIS

Technology:

Molecular, 2018-2031

Microbiology, 2018-2031

Immunoassay, 2018-2031

Total World, 2018-2031

TORCH TESTING

Total World, 2018-2031

EMERGING AND OTHER

Malaria, 2018-2031

Streptococcal, 2018-2031

Fungal, 2018-2031

Parasitic, 2018-2031

Lyme Disease, 2018-2031

RSV, 2018-2031

Emerging Infections, 2018-2031

Dengue fever, 2018-2031

All Other, 2018-2031

Total World, 2018-2031

COVID-19

Molecular Tests, 2018-2031

Immunoassays, 2018-2031

 

Chapter 4: Global Markets

Overview

  • Table 4-1a: Infectious Disease IVD Products Demand by Country, 2018-2025 (million dollars)
  • Table 4-1b: Infectious Disease IVD Products Demand by Country/Region, 2026-2031 (million dollars)

North America

  • Table 4-2a: North America:  Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 4-2b: North America:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

United States

  • Table 4-3a: United States:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-3b: United States:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Canada

  • Table 4-4a: Canada:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-4b: Canada:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Mexico

  • Table 4-5a: Mexico:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-5b: Mexico:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Western Europe

  • Table 4-6a: Western Europe:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-6b: Western Europe:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Germany

  • Table 4-7a: Germany:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-7b: Germany:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

France

  • Table 4-8a: France:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-8b: France:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

United Kingdom

  • Table 4-9a: United Kingdom:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-9b: United Kingdom:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Italy

  • Table 4-10a: Italy:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-10b: Italy:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Spain

  • Table 4-11a: Spain:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-11b: Spain:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Other Western Europe

  • Table 4-12a: Other Western Europe:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-12b: Other Western Europe:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Netherlands

Belgium

Sweden

Austria

Switzerland

Norway

Denmark

Portugal

Ireland

Greece

Finland

All Other Countries & Territories

Asia/Pacific

  • Table 4-13a: Asia/Pacific:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-13b: Asia/Pacific:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

China

  • Table 4-14a: China:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-14b: China:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

India

  • Table 4-15a: India:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-15b: India: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Japan

  • Table 4-16a: Japan:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-16b: Japan:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

South Korea

  • Table 4-17a: South Korea:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-17b: South Korea:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Other Asia/Pacific

  • Table 4-18a: Other Asia/Pacific:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-18b: Other Asia/Pacific:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Indonesia

Australia

Philippines

Thailand

Taiwan

Vietnam

Malaysia

Pakistan

Hong Kong

Singapore

New Zealand

All Other Countries & Territories

Other Regions

  • Table 4-19a: Other Regions:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-19b: Other Regions:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Central & South America

  • Table 4-20a: Central & South America:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-20b: Central & South America:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Brazil

Argentina

Colombia

Peru

Chile

All Other Countries & Territories

Eastern Europe

  • Table 4-21a: Eastern Europe:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-21b: Eastern Europe:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Russia

Poland

Romania

Czech Republic

Hungary

All Other Countries

Africa/Middle East

  • Table 4-22a: Africa/Middle East:  Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-22b: Africa/Middle East:  Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Turkey

Saudi Arabia

Iran

Egypt

Iraq

Nigeria

South Africa

Israel

United Arab Emirates

All Other Countries & Territories

 

Chapter 5: Company Profiles

Abbott Laboratories

Becton Dickinson and Company

Bio-Rad Laboratories

bioMérieux

Bruker Corporation

Danaher Corporation

DiaSorin

Grifols S.A.

Hologic

Ortho Clinical Diagnostics Holdings

QIAGEN

Quidel Corporation

Roche Holding

Immunoassays

COVID-19

Siemens Healthineers

Thermo Fisher Scientific

Microbiology

COVID-19

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and...COVID-19 Testing Market Update, 2022
Scroll to top